(Q39297461)

10 September 2017

title

The role of N-methyl-D-aspartate receptor subunit NR2B in spinal cord in cancer pain (English)

1 reference

10 September 2017

XiaoPing Gu

1

1 reference

10 September 2017

Juan Zhang

2

1 reference

10 September 2017

ZhengLiang Ma

3

1 reference

10 September 2017

JunHua Wang

4

1 reference

10 September 2017

XiaoFang Zhou

5

1 reference

10 September 2017

YanQing Jin

6

1 reference

10 September 2017

XiaoPing Xia

7

1 reference

10 September 2017

Qin Gao

8

1 reference

10 September 2017

FengMei Mei

9

1 reference

10 September 2017

publication date

7 October 2009

1 reference

10 September 2017

published in

European Journal of Pain

1 reference

10 September 2017

volume

14

1 reference

10 September 2017

issue

5

1 reference

10 September 2017

page(s)

496-502

1 reference

Fyn kinase-mediated phosphorylation of NMDA receptor NR2B subunit at Tyr1472 is essential for maintenance of neuropathic pain

10 September 2017

cites work

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Pain causes in 200 patients referred to a multidisciplinary cancer pain clinic

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Selective NMDA NR2B antagonists induce antinociception without motor dysfunction: correlation with restricted localisation of NR2B subunit in dorsal horn.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

The use of ketamine as adjuvant therapy to control severe pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Quantitative assessment of tactile allodynia in the rat paw

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

NMDA receptor blockade in chronic neuropathic pain: a comparison of ketamine and magnesium chloride

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Ketamine as an adjuvant for treatment of cancer pain in children and adolescents.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Group I metabotropic glutamate receptor NMDA receptor coupling and signaling cascade mediate spinal dorsal horn NMDA receptor 2B tyrosine phosphorylation associated with inflammatory hyperalgesia.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Differential efficacy of intrathecal NMDA receptor antagonists on inflammatory mechanical and thermal hyperalgesia in rats

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

A new and sensitive method for measuring thermal nociception in cutaneous hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Murine models of inflammatory, neuropathic and cancer pain each generates a unique set of neurochemical changes in the spinal cord and sensory neurons

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

NMDA receptor 2B subunit-mediated synaptic transmission in the superficial dorsal horn of peripheral nerve-injured neuropathic mice.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Tumor-evoked hyperalgesia and sensitization of nociceptive dorsal horn neurons in a murine model of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Antihyperalgesic and analgesic properties of the N-methyl-D-aspartate (NMDA) receptor antagonist neramexane in a human surrogate model of neurogenic hyperalgesia

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

The N-methyl-D-aspartate receptor subunit NR2B: localization, functional properties, regulation, and clinical implications.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Malignant bone pain: pathophysiology and treatment

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Recent progress in the pharmacotherapy of cancer pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Symptoms during cancer pain treatment following WHO-guidelines: a longitudinal follow-up study of symptom prevalence, severity and etiology

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Heteromeric NMDA receptors: molecular and functional distinction of subtypes

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Developmental and regional expression in the rat brain and functional properties of four NMDA receptors

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Synaptic distribution of the NR1, NR2A and NR2B subunits of the N-methyl-d-aspartate receptor in the rat lumbar spinal cord revealed with an antigen-unmasking technique

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

NMDA receptors as targets for drug action in neuropathic pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Breakthrough pain: characteristics and impact in patients with cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Ketamine and N-acetylaspartylglutamate peptidase inhibitor exert analgesia in bone cancer pain.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Anti-NGF therapy profoundly reduces bone cancer pain and the accompanying increase in markers of peripheral and central sensitization

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

mGlu and NMDA receptor contributions to capsaicin-induced thermal and mechanical hypersensitivity

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Spinal and supraspinal contributions to central sensitization in peripheral neuropathy

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Gene knockdown with intrathecal siRNA of NMDA receptor NR2B subunit reduces formalin-induced nociception in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Antinociceptive activity of CP-101,606, an NMDA receptor NR2B subunit antagonist

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Spinal NMDA receptor phosphorylation correlates with the presence of neuropathic signs following peripheral nerve injury in the rat.

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Alterations in dorsal horn neurones in a rat model of cancer-induced bone pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

NMDA receptor antagonist treatment at the time of nerve injury prevents injury-induced changes in spinal NR1 and NR2B subunit expression and increases the sensitivity of residual pain behaviours to subsequently administered NMDA receptor antagonists

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Neuronal plasticity: increasing the gain in pain

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

Ethical guidelines for investigations of experimental pain in conscious animals

21 January 2018

1 reference

https://api.crossref.org/works/10.1016%2FJ.EJPAIN.2009.09.001

10.1016/J.EJPAIN.2009.09.001

21 January 2018

Identifiers

DOI

1 reference

10 September 2017

1 reference